Suppr超能文献

长期无进展是心脏再同步治疗的一种反应形式。

Long-Term Nonprogression Is a Form of Response to Cardiac Resynchronization Therapy.

作者信息

Trenson Sander, Kahr Peter C, Vandenberk Bert, Schindler Matthias, Breitenstein Alexander, Saguner Ardan M, Flammer Andreas J, Ruschitzka Frank, Duru Firat, Steffel Jan, Winnik Stephan H

机构信息

University Heart Center, University Hospital Zurich, Zurich, Switzerland; Cardiovascular Sciences, University Hospital Leuven, Leuven, Belgium; Department of Cardiovascular Sciences, University Hospital Leuven, Leuven, Belgium.

University Heart Center, University Hospital Zurich, Zurich, Switzerland.

出版信息

JACC Adv. 2025 Jul 26;4(8):101909. doi: 10.1016/j.jacadv.2025.101909.

Abstract

BACKGROUND

Cardiac resynchronization therapy (CRT) reduces morbidity and mortality in selected heart failure patients. A distinct subpopulation (so-called "nonprogressors") of patients shows neither amelioration nor worsening of echocardiographic parameters after CRT implantation.

OBJECTIVES

The authors sought to investigate the long-term outcomes and prognosis of a distinct subpopulation of heart failure patients termed "nonprogressors," after CRT implantation.

METHODS

Retrospective single-center cohort analysis of 391 patients after CRT implantation. Based on echocardiography, patients were categorized into "super-responders" (Δ left ventricular ejection fraction [LVEF] >15% compared to baseline), "responders" (ΔLVEF >5% compared to baseline), "nonprogressors" (ΔLVEF ±5% compared to baseline), and "progressors" (ΔLVEF <-5% compared to baseline). The primary composite outcome was all-cause death, implantation of a ventricular assist device, or heart transplantation. Statistics included univariable and multivariable Cox proportional hazard regression analysis and Kaplan-Meier survival curves to explore outcome data.

RESULTS

Three hundred ninety-one patients (23% female, mean age 65 years, mean baseline LVEF 27%) were included. Postimplantation echocardiograms were performed after a mean of 37 months after CRT implantation. A total of 134 patients (34%) were nonprogressors. After a mean follow-up of another 57 months, progressors were significantly more likely to reach the composite endpoint of death, ventricular assist device implantation, or heart transplantation compared to nonprogressors (adjusted HR: 2.26 [95% CI: 1.35-3.78]; P = 0.002). Patients with positive echocardiographic response and super-response fared significantly better compared to nonprogressors.

CONCLUSIONS

Nonprogressors form a relevant, to date poorly characterized group of CRT patients, whose long-term survival is significantly better compared to progressors or negative responders.

摘要

背景

心脏再同步治疗(CRT)可降低特定心力衰竭患者的发病率和死亡率。有一部分特殊患者群体(即所谓的“无进展者”)在植入CRT后,其超声心动图参数既未改善也未恶化。

目的

作者试图研究植入CRT后被称为“无进展者”的特殊心力衰竭患者亚群的长期结局和预后。

方法

对391例植入CRT后的患者进行回顾性单中心队列分析。根据超声心动图,患者被分为“超反应者”(与基线相比,左心室射血分数[LVEF]增加>15%)、“反应者”(与基线相比,LVEF增加>5%)、“无进展者”(与基线相比,LVEF变化±5%)和“进展者”(与基线相比,LVEF降低<-5%)。主要复合结局为全因死亡、植入心室辅助装置或心脏移植。统计方法包括单变量和多变量Cox比例风险回归分析以及Kaplan-Meier生存曲线,以探索结局数据。

结果

纳入391例患者(23%为女性,平均年龄65岁,平均基线LVEF为27%)。在CRT植入后平均37个月进行植入后超声心动图检查。共有134例患者(34%)为无进展者。在平均随访另外57个月后,与无进展者相比,进展者达到死亡、心室辅助装置植入或心脏移植复合终点的可能性显著更高(校正后HR:2.26[95%CI:1.35 - 3.78];P = 0.002)。与无进展者相比,超声心动图有阳性反应和超反应的患者预后明显更好。

结论

无进展者是CRT患者中一个相关但迄今特征描述不足的群体,其长期生存率明显高于进展者或无反应者。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验